Workshops
| Date | Details |
|---|---|
| Day one 17:40 - 18:30 | Workshop session A |
| Wednesday 15 May A01: Horrors from Down Under IP experience, and in particular long term termination rates, in the Australian market have been poor in recent years. We will look to provide a summary of this experience and the potential reasons behind it. What lessons can we learn in the UK? In recent years there has been an increase in the ‘bells and whistles’ attached to policies sold in the UK features but how well is the impact of such features on claims experience understood and so how confident are we in our pricing and reserving? Speakers: Paul Morden, Munich Re and Speaker TBC
A02: Regenerative Medicine: Intelligent risk solutions and their potential value to the protection industry Regenerative medicines and in particular stem-cell based therapies are set to revolutionise healthcare, having the potential to cure disease. This is particularly critical in the context of an ageing population and given the pressures on social healthcare provision. The potential impact of regenerative medicines on the protection industry and the opportunity to develop new intelligent risk solutions will be discussed. Speakers: Dr Cathy Prescott, The Till Group and Sarah Bennett, Swiss Re
A03: Critical Illness claims experience CMI Critical Illness Committee – an update on the committee’s recent activity and future plans:
Speakers: James Tait, Pacific Life Re and Jamie Leitch, SCOR
A04: Predictive Modelling - not just an underwriting tool! Predictive modelling has many uses in the insurance industry. Whilst there has been significant focus on its use in underwriting and simplifying the process there are many other areas where it can prove its use. The session will demonstrate potential uses with examples from real models that have been built for different uses, including:
Speakers: Joan Coverson, Gen RE |
| Date | Details |
|---|---|
| Day two 10:00 - 10:50 | Workshop session B |
| Thursday 16 May B01: Long Term Care Insurance: Avoiding Potential Pitfalls (lessons from the US) Overview of the US market and how it has changed in the last decade:
Speaker: Winona Berdine, RGA
B02: Voluntary Income Protection Topics Voluntary group income protection products, where employees can choose whether to participate and what type of plan design to purchase, have become increasingly popular in the US. They pose numerous risk challenges, however, including adverse selection. This session explores methods to offer successful voluntary income protection by mitigating the risk through pricing, plan design, underwriting, and claim management. Speaker: Dan Skwire, Milliman
B03: Simplifiying the Underwriting Process The industry is discussing selling to the mass market and the need to simplify products. To achieve this the process needs simplifying. This talk will discuss the underwriting aspect of this. The presentation will discuss:
Speakers: Robert Kerr, Gen Re and John Downs, Scottish Widows
B04: IPMI – profitable growth opportunity or saturated market This presentation will cover:
Speakers: Ian Sissons and Stephen Bishop, Munich Health |
| Date | Details |
|---|---|
| Day two 11:20 - 12:10 | Workshop session C |
| C01: Why do people not tell us what we think they should - and what can we do about it? We know people always have, and always will, non-disclose. This talks looks at:
Speakers: Andrew Wibberley, Swiss Re and Rob Rosa, Millstream Medical Centre
C02: Whole of life disability products - customer friendly design or an actuary's worst pricing nightmare? Whole of life disability benefits (income protection and lump sum disability) were launched in South Africa in the last 18 months by Liberty. This presentation considers these benefits in more detail, particularly focusing on adherence to TCF principles, the need for customer and adviser-friendly design to ensure sales and the complexities involved in pricing these benefits. Speaker: Nicholas van der Nest, Liberty
C03: Solvency II ORSA – implications for Solvency II standard formula firms Justifying the use and appropriateness of the Standard Formula approach, the information and validation expected and how firms are tackling this. How to use the ORSA to complement the Standard Formula methodology, based on our experiences with insurance companies currently adopting the Standard Formula approach. This presentation also includes considerations surrounding the capital measures used and how to allow for risks identified in ORSA but not explicitly modelled by the Standard Formula. Lastly, the session would consider the impact of the Solvency II delays, including how to gain maximum benefits from the work already invested so far. Speakers: Christine Fairall and Matthew Murphy, KPMG
C04: Extending the critical path The Critical Illness Definitions and Geographical Variations Working parties have joined forces to produce a sequel to exploring the critical path, utilising the improved HES data described at last year’s conference. This session will present the group's findings on a selection of illnesses to demonstrate the scope of our investigations, as a preview to the contents of the final paper. Speakers: Members of the combined Critical Illness Working Parties |
| Date | Details |
|---|---|
| Day two 14:20 - 15:10 | Workshop session D |
| D01: Evidence based underwriting in health and Long Term Care Insurance Much underwriting today is based on medical opinion rather than real evidence. By developing a database with 100 million contract years of health insurance data it has become possible to model the human morbidity with a new level of precision. The data gives important insights for underwriting across health and life insurance. Combined with new technology for collecting medical history, it allows seemless, fully automated underwriting at the point-of-sale. Speaker: Dr Paul Triggs, Risk Consulting Prof. Dr. Weyer GMBH
D02: Lessons from the emerging markets Africa seems to be primed for growth in the life insurance market: Business can not be approached in the same way as in the developed world the speakers will share the experiences and lessons learnt, and look at the latest development in the use of technology in this continent. Speakers: Demetra La Grange, Munich Re and speaker TBC D03: Pricing IP with early intervention Ellipse launched InteractPlus in 2012, a group IP product with fully integrated absence management and early intervention. This session looks at the challenges in pricing such a product, including:
Speakers: Graham Lee and Samantha Spicer, Ellipse
D04: Critical Illness in Asia - a success story The Asian Markets are responsible for the highest volume of critical illness business sold worldwide. This presentation explores:
Speakers: Christian Cypris and Karsten de Braaf, SCOR Global Life SE |
| Date | Details |
|---|---|
| Day two 15:40 - 16:30 | Workshop session E |
| E01: Understanding consumer behaviour - what can statistics tell us? This session will cover:
Speakers: Aspasia Angelakopoulou and Vivian Chiu, Swiss Re Services Ltd
E02: No sex please we're British Following the turmoil and speculation of the protection industry implementing and adapting to the changes imposed by the Gender Directive in 21/12/12, this session will look back on what was anticipated and what the industry actually saw. The session will focus specifically on:
Speakers: Adrian Stevenson, Munich Re and Scott Reid, Ageas Protect
E03: Risk transfer to providers: lessons learnt Risk transfers to medical providers is a hot topic in both the NHS and in several overseas markets. This session will examine the issues and lessons using some real life case studies covering a range of different risk sharing arrangements, including provider capitation, outcomes based contracting and risk-sharing/gain sharing arrangements. Speakers: Joanne Buckle, Milliman and Dr Diane Gray, Bedfordshire Clinical Commissioning Group
E04: Insights into recent Income Protection experience by cause of sickness CMI IP Committee – an update on the committee’s recent activity and future plans:
Speakers: Duncan Heald, SCOR and Hannah Cook, Legal & General |
| Date | Details |
|---|---|
| Day three 10:00 - 10:50 | Workshop session F |
| Friday 17 May F01: Work-motivating interviews and claims management David Imber from RNL and the Swiss Re claims team have trialled a BTEC-accredited course to teach effective work-focussed conversations skills that help disabled and ill claimants back into work. We will demonstrate how the approach:
Vocational rehabilitation and claims experts have traditionally worked in isolation despite sharing goals. Our interaction is the missing link to more skilful work-focussed discussions. Speakers: Sarah Fielding, Swiss Re and David Imber, Rehabilitiation Network
F02: What can business learn from poker players This is a commercial skills session, taking a look at how poker players aim to make profitable decisions and draws out some potential parallel learnings for Business. Areas covered include:
Speaker: Tony Horn, Positive EV Ltd
F03: Reinsurance structuring under Solvency II The effects of reinsurance under Solvency II are not straight forward and depend heavily on an insurer’s model choices. This presentation will discuss the potential impact of different reinsurance structures and demonstrate the efficiency of such solutions. Speaker: John Woodford, Munich Re
F04: Update from the long term care working party following the decision to implement Dilnot This presentation will cover:
Speakers: Hamish Wilson, Hymans Robertson and Ian Sissons, Munich Re |
| Date | Details |
|---|---|
| Day three 11:20 - 12:10 | Workshop session G |
| G01: Group mentality – developments and pressures in the Group Risk market This session will cover:
Speakers: James Shattock and Keith Jennings, UNUM
G02: Beagle Street - the building of a new online brand Beagle Street – the journey so far...
Speakers: Matthew Gledhill and David Wells, Beagle Street
G03: From small things big things one day come: the future of cancer diagnosis Cancer is the major cause of claim for critical illness products. We look at the diagnosis of cancer and the drivers behind the screening industry. We discuss the recently introduced pilot study using molecular tests to diagnose lung cancer and how this is planned to be rolled out to diagnose other cancers much earlier including breast, colon and ovarian cancers. We will discuss the implications of this technology on critical illness pricing. Speakers: Adele Groyer, Gen Re and Dr Ian Cox, Gen Re
G04: Providing affordable health solutions for the grey market The PMI market remains flat at best and the cost of full cover is prohibitive for the vast majority of older lives. This session examines the scope to offer widely affordable medical cover to the Over 50's mass market by:
Speakers: Peter Mannion, Redmayne Consulting and Jan Lawson, Private Healthcare Partnership
Please note the programme is subject to change and cancellations. |